B7-Negative Versus B7-Positive P815 Tumor: Differential Requirements for Priming of an Antitumor Immune Response in Lymph Nodes

Journal of Immunology

Volumn 158, Issue 2, 1997, Pages 851-858

  Yang, Guchen ^a   Mizuno, Mark T ^a   Hellström, Karl Erik ^a   Chen, Lieping ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; L SELECTIN; MONOCLONAL ANTIBODY;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; C3H MOUSE; CANCER TRANSPLANTATION; CELL CULTURE; CELL MOTION; COMPARATIVE STUDY; CYTOTOXIC T LYMPHOCYTE; DBA MOUSE; DRUG EFFECT; FEMALE; IMMUNIZATION; IMMUNOLOGY; IMMUNOSURVEILLANCE; LYMPH NODE; MELANOMA; METHODOLOGY; MOUSE; SARCOMA;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; ANTIGENS, CD80; CELL MOVEMENT; FEMALE; IMMUNIZATION; IMMUNOLOGIC SURVEILLANCE; L-SELECTIN; LYMPH NODES; MAST-CELL SARCOMA; MELANOMA; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED DBA; NEOPLASM TRANSPLANTATION; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0031567899     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Mueller, D. L., M. K. Jenkins, and R. H. Schwartz. 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signaling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7:445.
2. Inaba, K., M. Witmer-Pack, M. Inaba, K. S. Hathcock, H. Sakuta, M. Azuma, H. Yagita, K. Okumura, P. S. Linsley, S. Ikehara, S. Muramatsu, R. J. Hodes, and R. M. Steinman. 1994. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 180:1849.
3. Picker, L. J., and E. C. Butcher. 1992. Physiological and molecular mechanisms of lymphocyte homing. Annu. Rev. Immunol. 10:561.
4. Linsley, P. S., and J. A. Ledbetter. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191.
5. Hathcock, K. S., G. Laszlo, C. Pucillo, P. S. Linsley, and R. J. Hodes. 1994. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J. Exp. Med. 180:631.
6. Linsley, P. S., W. Brady, M. Urnes, L. S. Grosmaire, N. K. Damle, and J. A. Ledbetter. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:561.
7. Boussiotis, V. A., G. J. Freeman, G. Gray, J. Gribben, and L. M. Nadler. 1993. B7 but not ICAM-1 costimulation prevents the induction of human alloantigen specific tolerance. J. Exp. Med. 178:1753.
8. Chen, L., P. S. Linsley, and K. E. Hellström. 1993. Costimulation of T cells for tumor immunity. Immunol. Today 14:483.
9. Hellström, K. E., I. Hellström, and L. Chen. 1995. Can costimulated tumor immunity be therapeutically efficacious? Immunol. Rev. 145:123.
10. Chen, L., S. Ashe, W. A. Brady, I. Hellström. K. E. Hellström, J. A. Ledbetter, P. McGowan, and P. S. Linsley. 1992. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71:1093.
11. + T cells by B7-transfected melanoma cells. Science 259:368.
12. Chen, L., P. McGowan, S. Ashe, J. Johnston, Y. Li, I. Hellström, and K. E. Hellström. 1994. Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J. Exp. Med. 179:523.
13. Baskar, S., S. Ostrand-Rosenberg, N. Nabavi, L. M. Nadler, G. J. Freeman, and L. H. Glimcher. 1993. Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated MHC class II molecules. Proc. Natl. Acad. Sci. USA 90:5687.
14. + T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma. J. Immunol. 153:421.
15. Ramarathinam, L., M. Castle, Y. Wu, and Y. Liu. 1994. T cell costimulation by B7/BB1 induces CDS T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells. J. Exp. Med. 179:1205.
16. Yang. G., K. E. Hellström. I. Hellström, and L. Chen. 1995. Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA4 costimulatory molecules. J. Immunol. 154:2794.
17. + cytolytic T lymphocytes. J. Exp. Med. 183:791.
18. Li, Y., K. E. Hellström, S. A. Newby, and L. Chen. 1996. Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors. J. Exp. Med 183:639.
19. Kündig, T. M., M. F. Bachmann, C. DiPaolo, J. J. L. Simard, M. Battegay, H. Lother, A. Gessner, K. Kühlcke, P. S. Ohashi, H. Hengartner, and R. M. Zinkernagel. 1995. Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science. 268:1343.
20. Bevan, M. J. 1976. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143:1283.
21. Shahinian, A., K. Pfeffer, K. P. Lee, T. M. Kündig, K. Kishihara, A. Wakeham, K. Kawai, P. S. Ohashi, C. B. Thompson, and T. W. Mak. 1993. Deferential T cell costimulatory requirements in CD28-delicient mice. Science 261:609.
22. Green, J. M., P. J. Noel, A. I. Sperling, T. L. Walunas, G. S. Gray, J. A. Bluestone, and C. B. Thompson. 1994. Absence of B7-dependent responses in CD28-deficient mice. Immunity 1:501.
23. Wu, Y., Y. Guo, and Y. Liu. 1993. A major costimulatory molecule on antigen-presenting cells, CTLA4 ligand A, is distinct from B7. J. Exp. Med. 178:1789.
24. Finck, B. K., P. S. Linsley, and D. Wofsy. 1994. Treatment of murine lupus with CTLA4Ig. Science 265:1225.
25. Weinhold, K. J., L. T. Goldstein, and E. F. Wheelock. 1979. The tumor dormant state: quantitation of L5178Y cells and host immune responses during the establishment and course of dormancy in syngeneic DBA/2 mice. J. Exp. Med. 149:723.
26. Chen, L., E. K. Thomas, S.-K. Hu, I. Hellström, and K. E. Hellström. 1991. Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen. Proc. Natl. Acad. Sci. USA 88:110.
27. Chen, C., and N. Nabavi. 1994. In vitro induction of T cell anergy by blocking B7 and early T cell costimulatory molecule ETC-1/B7-2. Immunity 1:147.
28. Zhang, Y., R. J. J. van Neerven, A. Kasran, M. de Boer, and J. L. Ceuppens. 1996. Differential requirements for costimulatory signals from B7 family members by resting versus recently activated memory T cells towards soluble recall antigens. Int. Immunol. 8:37.
29. Yang, G., and L. Chen. 1996. Costimulation in immune responses against tumors. In Molecular Approaches to Tumor Immunotherapy. Y. Liu, ed. World Scientific, Inc., New York, in press.
30. Huang, A. Y. C., P. Golumbek, M. Ahmadzadeh, E. Jaffee, D. Pardoll, and H. Levitsky. 1994. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264:961.
31. + T cells by delivery of the B7 costimulatory signal on bystander antigen-presenting cells (trans-costimulation). Eur. J. Immunol. 24:859.
32. Macatonia, S. E., C. S. Knight, A. J. Edward, S. Griffiths, and P. Fryer. 1987. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate: functional and morphological studies. J. Exp. Med. 166:1654.
33. Bradley, L. M., S. R. Watson, and S. L. Swain. 1994. Entry of naive CD4 T cells into peripheral lymph nodes requires L-selectin. J. Exp. Med. 180:2401.
34. Lepault, F., M. C. Gagnerault, C. Faveeuw, and C. Boitard. 1994. Recirculation, phenotype and functions of lymphocytes in mice treated with monoclonal antibody MEL-14. Eur. J. Immunol. 24:3106.
35. Arbones, M. L., D. C. Ord, K. Ley, H. Ratech, C. Maynard-Curry, G. Otten, D. J. Capon, and T. F. Tedder. 1994. Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity 1:247.
36. Xu, J., I. S. Grewal, G. P. Geba, and R. A. Flavell. 1996. Impaired primary T cell responses in L-selectin-deficient mice. J. Exp. Med. 183:589.
37. Khazaie, K., S. Prifti, P. Beckhove, A. Griesbach, S. Russell, M. Collins, and V. Schirrmacher. 1994. Persistence of dormant tumor cells in the bone marrow of tumor cell-vaccinated mice correlates with long-term immunological protection. Proc. Natl. Acad. Sci. USA 91:7430.
38. Lindemann, F. G., F. Schlimok, P. Dirschedl, J. Witte, and G. Riethmuller. 1992. Prognostic significance of micrometastic tumor cells in bone marrow of colorectal cancer patients. Lancet 340:685.
39. Liotta, L. A., and W. G. Stetler-Stevenson. 1989. Principles of molecular cell biology of cancer: cancer metastasis. In Cancer, Principles and Practice of Oncology, 3rd Ed. V. T. DeVita, Jr., S. Hellman, and S. A. Rosenberg, eds. J. B. Lippincott, Philadelphia, p. 98.
40. Old, K. J., and E. A. Boyse. 1964. Immunology of experimental tumors Annu. Rev. Med. 15:167.